- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02539030
Comparison of Efficacy and Safety of Microfracture and Modified Microfracture
Random Clinical Trial for Comparison of Efficacy and Safety of Simple Microfracture and Modified Microfracture Using Collagen in the Patients With Knee Cartilage Defects
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Daejeon, Korea, Republic of
- Daejeon Sun hospital
-
Incheon, Korea, Republic of
- Inha University Hospital
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
Seoul, Korea, Republic of
- Ewha Womans University Mokdong Hospital
-
Seoul, Korea, Republic of
- Samsung Medical Center
-
Seoul, Korea, Republic of
- The Catholic University of Korea Seoul St. Mary's Hospital
-
Seoul, Korea, Republic of
- Inje University Seoul Paik Hospital
-
Seoul, Korea, Republic of
- The Catholic University of Korea St. Paul's Hospital
-
Seoul, Korea, Republic of
- Seoul Metropolitan Government Seoul National University Boramae Medical Center
-
-
Gyeonggi
-
Bucheon, Gyeonggi, Korea, Republic of
- The Catholic University of Korea Bucheon St. Mary's Hospital
-
Suwon, Gyeonggi, Korea, Republic of
- The Catholic University of Korea Vincent's Hospital
-
-
Jeollabuk-do
-
Iksan, Jeollabuk-do, Korea, Republic of
- Wonkwang University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1. Patients with cartilage defects in their knee (Including Knee OA and Knee TA) 2. Knee osteoarthritis patients whose Kellgren-Lawrence Grading Scale score is lower than 3 (patients who received simultaneous or previous correction will be excluded).
3. Patients with misalignment of their tibia and femur, unstable ligament in their knee, or bony defects in the lesions of their knee, and/or who had been treated for alignment 4. Patients who were 15 years old or older 5. Patients or their representative (for adults), or patients and their parent/guardian (for minors), who agreed to participate in the study and signed the informed consent form
Exclusion Criteria:
1. If patients or their families suffer from or have ever suffered from an autoimmune disease.
2. Patients who have ever suffered an anaphylactic reaction. 3. Patients who have ever suffered hypersensitivity to an implant. 4. Patients with a history of allergy to porcine or bovine protein. 5. Subjects with inflammatory arthritis, such as rheumatoid and gouty arthritis.
6. Subjects with autoimmune disease related arthritis. 7. Subjects who are pregnant and/or breast-feeding and/or plan a pregnancy. 8. Subjects with tumors. 9. Subjects who have undergone radiotherapy or chemotherapy within the last 2 years (Exception: if the possibility of collagen treatment is confirmed with doctor's clinical decision).
10. Subjects who are diabetic. (Exception: if the possibility of CartiFill™ treatment is confirmed with doctor's clinical decision, and/or patient's blood glucose level remains within the normal range and/or no other complications by diabetes mellitus.) 11. Subjects with infections, currently on treatment with antibiotics or antimicrobials (Exception: if the possibility of collagen treatment is confirmed with doctor's clinical decision).
12. Subjects under adrenocorticoid therapy (Exception: if the possibility of collagen treatment is confirmed with doctor's clinical decision).
13. Subjects with psychiatric disorders who are considered inappropriate to participate in this trial by the Principal Investigator.
14. Patients who have ever suffered contraindications of the used Fibrin sealant. (The major contraindications are as follows: patients with hypersensitivity to aprotinin and those treatments for severe brisk arterial or venous bleeding.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: microfracture
simple microfracture for cartilage defect of knee
|
simple microfracture
|
Experimental: modified microfracture using collagen
modified microfracture using collagen (CartiFill) for cartilage defect of knee
|
add collagen when doing microfracture
simple microfracture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
100mmVAS(Visual Analogue Scale)
Time Frame: 12 month after surgery
|
It will be evaluated by the VAS score 12 months after surgery of the affected knee of the investigational group and the control group.
|
12 month after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of 100 mmVAS (Visual Analogue Scale)
Time Frame: screening, 3, 6, 12 and 24 months after surgery
|
The difference between the VAS scores of the affected knee at the screening and 12 months after surgery in the investigational group will be compared to that in the control group.
The differences in the VAS scores obtained at the follow-ups (3, 6, and 24 months after surgery) will be compared.
|
screening, 3, 6, 12 and 24 months after surgery
|
change of Knee injury and osteoarthritis outcome (KOOS)
Time Frame: screening, 6, 12 and 24 months after surgery
|
The difference between the KOOS scores of the affected knee at the screening and 12 months after surgery in the investigational group will be compared to that in the control group.
The differences in the KOOS scores obtained at the follow-ups (6 and 24 months after surgery) will be compared.
|
screening, 6, 12 and 24 months after surgery
|
change of International Knee Documentation Committee (IKDC)
Time Frame: screening, 6, 12 and 24 months after surgery
|
The difference between the IKDC scores of the affected knee at the screening and 12 months after the surgery in the investigation group will be compared to that in the control group.
The differences in the IKDC scores obtained at the follow-ups (6 and 24 months after surgery) will be compared.
|
screening, 6, 12 and 24 months after surgery
|
the results of MRI and MRI of articular cartilage examination (T2, T2 star, deGEMRIC, UTE, etc.), mMOCART
Time Frame: 12 months after surgery
|
The results obtained 12 months after the surgery on the affected knee in the investigational and control groups will be described. mMOCART will be obtained, and the difference will be assessed. * Depending on the MRI equipment, if in-house imaging is not possible, it may be done at the other hospitals conducting the research. |
12 months after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yong In, MD, The Catholic University of Korea
- Principal Investigator: Nam Yong Choi, MD, Catholic University of Korea Saint Paul's Hospital
- Principal Investigator: Chan Woong Moon, MD, The Catholic University of Korea Bucheon St.Mary's Hospital
- Principal Investigator: Hae Seock Ko, MD, The Catholic University of Korea Vincent's Hospital
- Principal Investigator: Cheol Hong Jeon, MD, Wonkwang University Hospital
- Principal Investigator: Seung Back Kang, MD, SMG-SNU Boramae Medical Center
- Principal Investigator: Ja Young Choi, MD, Seoul National University Hospital
- Principal Investigator: Myung Koo Kim, MD, Inha University Hospital
- Principal Investigator: Jae Kyun Jun, MD, Daejeon Sun hospital
- Principal Investigator: Jung Koo Ha, MD, Inje University
- Principal Investigator: Jun Ho Wang, MD, Samsung Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03CAR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Sanford HealthActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
University of EdinburghHospital for Special Surgery, New YorkRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
University of VermontCompletedOsteoarthritis of Knee | Osteoarthritis Of HipUnited States
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Ottawa Hospital Research InstituteNot yet recruitingKnee Osteoarthritis | Hip Osteoarthritis
-
University Hospital, LilleCompleted
-
Massachusetts General HospitalNewton-Wellesley Hospital; The New England Baptist HospitalCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
Clinical Trials on CartiFill
-
Sewon Cellontech Co., Ltd.UnknownDefect of Articular CartilageKorea, Republic of